Production of the lymphokine costimulator by activated mouse splenocytes under controlled conditions
Bödeker, B.G.; Lehmann, J.; Mühlradt, P.F.
Developments in Biological Standardization 46: 231-237
1980
ISSN/ISBN: 0301-5149 PMID: 7364151 Document Number: 160965
CBA/J mouse splenocytes were induced by concanavalin A to produce the lymphokine costimulator. No serum was needed for this process. Culture conditions were optimized in a 250 ml reactor vessel. While variations of the pH or agitation by stirring had no influence, high dissolved oxygen was found to increase the yields of costimulator even at the cost of cell viability.
Document emailed within 1 workday
Related Documents
Bout, D.T.; Joseph, M.; David, J.R.; Capron, A.R. 1981: In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages Journal of Immunology 127(1): 1-5Marincola, F.M.; Da Pozzo, L.F.; Drucker, B.J.; Holder, W.D. 1990: Adoptive immunotherapy of human pancreatic cancer with lymphokine-activated killer cells and interleukin-2 in a nude mouse model Surgery 108(5): 919-929
Thomson, A.W.; Moon, D.K.; Nelson, D.S. 1983: Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin a in the mouse Clinical and Experimental Immunology 52(3): 599-606
Sakata, K.; Tashiro, K.; Hirashima, M.; Hayashi, H. 1985: Selective regulation of chemotactic lymphokine production. I. Selective potentiation of eosinophil chemotactic lymphokine production in alum hydroxy gel- and Bordetella pertussis vaccine-treated guinea pigs Journal of Immunology 135(5): 3463-3467
Lamers, H.J.; Gratama, J.W.; van Putten, W.L.; Stoter, G.; Bolhuis, R.L. 1991: Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes Cancer Research 51(9): 2324-2328
Blaser, C.; Kaufmann, M.; Pircher, H. 1998: Virus-activated CD8 T cells and lymphokine-activated NK cells express the mast cell function-associated antigen, an inhibitory C-type lectin Journal of Immunology 161(12): 6451-6454
Hayama, T.; Ponzio, N.M.; Nagler, C.; Vilcek, J.; Coico, R.F.; Thorbecke, G.J. 1984: Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. III. Relative roles of reticulum cell sarcoma and normal lymphoid cells in lymphokine production Journal of the National Cancer Institute 72(2): 321-331
Field, E.H.; Ye, Z.X.; Rouse, T.M. 1996: Mechanisms of tolerance induction: splenocytes from total lymphoid irradiated mice inhibit the IL-2 pathway in TCR-activated CD4 cells Journal of Immunology 157(9): 3796-3803
Heine, J.W.; Adler, W.H. 1976: The kinetics of interferon production by mouse lymphocytes and its modulating effect of the virus plaqueforming cell assay as a quantitative method to determine activated lymphocytes Journal of Immunology 117(3): 1045-1048
Glassman, A.B. 1989: Interleukin-2 and lymphokine activated killer cells: promises and cautions Annals of Clinical and Laboratory Science 19(1): 51-55
Lynch, D.H.; Miller, R.E. 1990: Induction of murine lymphokine-activated killer cells by recombinant IL-7 Journal of Immunology 145(6): 1983-1990
Tani, M.; Tanimura, H.; Yamaue, H.; Tsunoda, T.; Iwahashi, M.; Noguchi, K.; Tamai, M.; Hotta, T.; Mizobata, S. 1993: Augmentation of lymphokine-activated killer cell activity by lentinan Anticancer Research 13(5c): 1773-1776
Hamada, F.; Fuchimoto, S.; Orita, K. 1989: Suppression of lymphokine activated killer (LAK) cells by immunosuppressive substance Research Communications in Chemical Pathology and Pharmacology 65(1): 81-95
Sniecinski, I.J. 1989: Lymphokine-activated killer lymphocytes: extramural clinical trials Immunology Series 48: 59-77
Jíra, M.; Malkovský, M.; Denman, A.M.; Loveland, B.; Lyons, D.; Dalgleish, A.G.; Webster, A.D. 1987: Lymphokine-activated killer cell activity in rheumatoid arthritis Clinical and Experimental Immunology 68(3): 535-542
Skvortsova, R.G.; Kidreĭ, E.G.; Malyshev, V.V. 1993: Electrophoretic mobility of mouse splenocytes in evaluation of the effect of stress on the immune response Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 38-39
Hirakawa, Y. 1985: Immunological studies on herpetic keratitis. Induction of cytotoxic T lymphocytes in mouse splenocytes Nippon Ganka Gakkai Zasshi 89(1): 208-213
Ballas, Z.K.; Rasmussen, W. 1990: Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations Journal of Immunology 144(1): 386-395
Nakano, E. 1992: Lymphokine-activated killer (LAK) therapy for metastatic renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1305-1309
Akarid, K.; Pocidalo, M.A.; Desforges, B.; Sinet, M. 1995: Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS) European Cytokine Network 6(3): 181-185